期刊文献+

病理性瘢痕组织中Survivin、P33ING1、Caspase-3蛋白的表达 被引量:1

Expression of Survivin, P33ING1, and Caspase-3 proteins in pathologic scar tissue
下载PDF
导出
摘要 目的检测病理性瘢痕组织中Survivin、P33ING1、Caspase-3蛋白的表达情况。方法采用免疫组织化学方法检测30例病理性瘢痕组织、10例非病理性瘢痕和20例正常皮肤组织中Survivin、P33ING1、Caspase-3的表达情况。结果病理性瘢痕、非病理性瘢痕和正常皮肤组织中Survivin、P33ING1和Caspase-3的阳性表达率分别为80.0%、50.0%、35.0%,43.3%、70.0%、85.0%和30.0%、80.0%、90.0%;病理性瘢痕组织与非病理性瘢痕和正常皮肤组织比较,3指标差异均有统计学意义(P<0.05)。病理性瘢痕组织中Caspase-3与Survivin(r=-0.400)和P33ING1(r=0.602)表达均具有相关性(P<0.05)。结论Survivin的高表达与Caspase-3和P33ING1的表达下调在病理性瘢痕的形成中可能起协同作用。 Aim: To investigate the expressions of apoptosis-related Survivin, P33ING1, and Caspase-3 in pathologic scar formation. Methods: The expressions of Survivin, P33ING1, and Caspase-3 in 30 cases of pathologic scar, 10 cases of non-pathologic scars, and 20 cases of normal skin tissue were detected using immunohistochemical methods, Results: The positive rates of survivin, P33ING1, and Caspase-3 in pathologic scar, non-pathologic scar, and normal skin tissue were 80.0% ,50.0% ,35.0% ,43, 3% ,70.0% ,85.0% and 30.0% ,80.0% ,90.0% , respectively, Compared with non- pathologic scar and normal skin cases, the expressions of Survivin, P33ING1 , and Caspase-3 had significant difference in pathologic scar cases(P 〈 0.05). Caspase-3 expression were correlated with Survivin ( r = - 0. 400 ) and P33ING1 ( r - 0.602) in pathologic scar tissue (P 〈 0. 05 ). Conclusion: The uverexpression of Survivin and down-regulation of Caspase-3 and P33ING1 expressions may play a coordinated role in pathologic scars.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2006年第6期1038-1041,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目971901300
关键词 增生性瘢痕 瘢痕疙瘩 SURVIVIN P33ING1 CASPASE-3 hypertrophic scar keloid Survivin P33 ING1 Caspase-3
  • 相关文献

参考文献10

  • 1Wassermann R J, Polo M, Smith P, et al. Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res, 1998,75 (1):74
  • 2赵新汉,马欣,李琳琳,李晶,刘陕西.Caspase-3和Bcl-2在白血病细胞株凋亡过程中的表达及其与多药耐药的关系[J].西安交通大学学报(医学版),2005,26(6):581-585. 被引量:9
  • 3Polyak K, Xia Y, Zweier JL, et al. A model for p53-indueed apoptosis. Nature, 1997,389 ( 6 648 ) : 300
  • 4Takahashi R, Deveraux Q, Tamm I ,et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem, 1998,273(14) :7 787
  • 5Suzuki A,Ito T, Kawano H,et al. Survivin initiates ptrocapase 3/P21 complex formation as a result of interaction with CDK4 to resist Fas-mediated cell death. Oncogene ,2000,19 (10) : 1 346
  • 6Pearl-Yale M, Halperin D, Scheuerman O, et al, The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmaeol, 2004,67 ( 3 ) :539
  • 7赵新汉,田洪刚,全平,刘陕西.促凋亡蛋白Caspase-3与白血病细胞耐药的相关性[J].西安交通大学学报(医学版),2005,26(5):463-466. 被引量:4
  • 8Campos El, Xiao H, Li G. Generation of a polyclonal antibody specifically against the p33 ( ING1 b) tumor suppressor.Immunoassay Immunochem, 2004,25 ( 1 ) : 71
  • 9Helbing CC, Veillete C, Riabowol K, et al. A novel candidate tumor suppressor, ING1 is involved in the regulation of apoptosis. Cancer Res, 1997,57(7):1 255
  • 10Oki E, Machara Y, Tokunage E, et al. Reduced expression of p33 ( ING1 ) and the relationship with p53 expression in human gastric cancer. Cancer Lett, 1999,47 ( 1/2 ) : 157

二级参考文献30

  • 1Carrion C, Madariaga MA, Domingo JC. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34+ leukemic cells [J]. Life Sci, 2004,75(6) :313-328.
  • 2Gelder T, Hesselink DA, Hest RM, et al. Pharmacogenetics in immunosuppressive therapy-the best thing since TDM [J] ? Ther Drug Monit, 2004, 26(4) :343-346.
  • 3Jonsson-Videsater K, Bjorkhem-Bergman L, Hossain A, et al. Selenite-induced apoptosis in doxorubicin-resistant cells and effectson the thioredoxin system[J]. Biochem Pharmacol, 2004, 67(12) :513-522.
  • 4Soto-Cerrato V, Llagostera E, Montaner B, et al. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin [J]. Biochem Pharmacol, 2004, 68(12) : 1345- 1352.
  • 5Lo MY, Kim HT. Chondrocyte apoptosis induced by hydrogen peroxide requires caspase activation but not mitochondrial pore transition [J]. J Orthop Res, 2004, 22(6) : 1120- 1125.
  • 6Yang YN, Zhao S, Song JG. Caspase-dependent apoptosis and - independent poly (ADP-ribose)polymerase cleavage induced by transforming growth factor β1 [J]. Int J Biochem Cell Biol, 2004, 36(6) :223-234.
  • 7Shiozaki EN, Shi YG. Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology [J]. Trends Biochem Sci, 2004, 29(9):486-494.
  • 8Abraham MC, Shaham S. Death without caspases, caspases without death [J]. Trends Cell Biol, 2004,14(4) :184- 193.
  • 9Karvinen J, Elomaa A, Makinen ML, et al. Caspase multiplexing: simultaneous homogeneous time-resolved quenching assay (TruPoint) for caspases 1, 3, and 6 [J]. Anal Biochem, 2004, 325(2) :317-325.
  • 10Martin AG, Nguyen J, Wells JA, et al. Apo cytochrome c inhibits caspases by preventing apoptosome formation[J]. Biochem Biophy Res Commun, 2004, 319(6) :944-950.

共引文献10

同被引文献7

  • 1Sally P,Wheatley,Iain A,et al.Survivin:A protein with dual roles in mitosis and apoptosis[J].Inte Rev of Cytol,2005,247:35-88.
  • 2Walker J,Martin C,Callaghan R.Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy[J].Euro J Cancer,2002,40(4):594-605.
  • 3Jason Z,John J,Mandeep B,et al.Enhanced cellular accumulation of a P-glycoprotein substrate,rhodamine-123,by caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers[J].Euro J Phar and Biopharmaceutics,2002,54(3):299-309.
  • 4Julio ED,Enrich C,Xavier GDM,et al.Expression of multidrug resistance proteins p-glycoprotein,multidrug resistance protein 1,breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy:biological and clinical implications[J].J Urol,2003,170(4):1383-1387.
  • 5Nadia Z,Maria GD.Survivin expression and resistance to anticancer treatments:perspectives for new therapeutic interventions[J].Drug Resistance Updates,2002,5(2):65-72.
  • 6Tetsuhisa Y,Yoshinobu M,Motoyuki N,et al.Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer[J].Euro J Cancer,38(17):2316-2324.
  • 7Pawlik A,Baskiewicz M,Machalinski B,et al.Involvement of P-gp in the process of apoptosis in peripheral blood mononuclear cells[J].Inte Immunopharmacol,2005,5(5):821-828.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部